Calidad de vida en pacientes con enfermedad inflamatoria intestinal atendidos en tres hospitales del Seguro Social en Ecuador (Quito, Guayaquil y Cuenca)
DOI:
https://doi.org/10.29166/rfcmq.v43i2.2826Keywords:
Inflammatory bowel disease, quality of life, ulcerative colitis, Crohn’s diseaseAbstract
Background: Inflammatory bowel disease (IBD) is a chronic inflammatory process of the intestine with its two varieties, ulcerative colitis and Crohn’s. The goal of treatment is the clinical and endoscopic remission of the disease. However, the quality of life that influences the management and evolution of the disease is usually overlooked. Aim: To determine the quality of life and related factors in patients with IBD treated in three hospitals of Ecuadorian Social Security. Methods: Epidemiological, observational, descriptive and cross-sectional study in patients over 18 years of age diagnosed with IBD, who attend the gastroenterology service of three hospitals: Carlos Andrade Marin, Jose Carrasco Arteaga and Teodoro Maldonado, in the period January to June 2018. Results: 50 patients were evaluated, 68% (n=34) with UC and 32% (n=16) with CD. The average age was 48 +/- 9 years for CU and 42+/- 7 years in CD. A male female ratio of 1.6: 1 was determined. 30% of the patients evaluated (n=15) perceived their quality of life as low. Statistically significant differences were found in relation to the type of IBD (CD, p 0.03), female sex (p 0.04) and the presence of relapses (p 0.04). Conclusions: The quality of life in patients with inflammatory bowel disease was perceived as lower in female patients than those with CD and in those with one or more relapse episodes during the last semester
Downloads
Metrics
References
Yamamoto JK. Inflammatory bowel disease. Current treatment for IBS. Rev Gastroenterol Mex 2010;
(1):149-51.
Ueno F, Nakayama Y, Hagiwara E, Kurimoto S, Hibi T. Impact of inflammatory bowel disease on
Japanese patients’ quality of life: results of a patient questionnaire survey. J Gastroenterol 2017;
(5):555-67.
Kusugami K, Ina K, Ando T, Hibi K, Nishio Y, Goto H. Immunomodulatory therapy for inflammatory bowel disease. J Gastroenterol 2004; 39(12):1129-37.
Gili M, Bauzá N. Calidad de vida y personalidad en la enfermedad inflamatoria intestinal. Gastroenterol Hepatol 2009; 32(2):3-8.
Vergara M, Casellas F, Badia X, Malagelada JR. Assessing the quality of life of household members
of patients with inflammatory bowel disease: development and validation of a specific questionnaire.
Am J Gastroenterol 2002; 97:1429-1437.
Masachs M, Casellas F, Malagelada JR. Traducción, adaptación y validación al español del cuestionario de calidad de vida de 32 ítems (IBDQ-32) de la enfermedad inflamatoria intestinal. Rev Esp
Enferm Dig 2007; 99:511-519.
Veitia G, Pernalete B, La Cruz M, Aldana G, Cachima L, Istúriz R, et al. Percepción de calidad de
vida determinada por cuestionario IBDQ-32, en pacientes con enfermedad inflamatoria intestinal.
Revista Gen 2012; 66(3):155-159.
Jowett SL, Seal CJ, Barton JR, Welfare MR. The short inflammatory bowel disease questionnaire is
reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol 2001;
(10): 2921-8.
Huppertz-Hauss G, Høivik ML, Langholz E, Odes S, Småstuen M, Stockbrugger R, et al. Health-related quality of life in inflammatory bowel disease in a european-wide population-based cohort 10
years after diagnosis. Inflammatory Bowel Diseases 2015; 21(2):337-344.
López Cortés R, Marín Fernández B, Hueso Montoro C, Escalada Hernández P, Sanz Aznarez A.C,
Rodríguez Gutiérrez C. Calidad de vida relacionada con la salud en pacientes con enfermedad inflamatoria intestinal. Anales Sis San Navarra 2016; 39(1):123-131.
Ojeda C, Cofré C. Calidad de vida relacionada con la salud en pacientes pediátricos con enfermedad
inflamatoria intestinal. Rev Chil Pediatr 2018; 89(2):196-201.
Moradkhani A, Beckman LJ, Tabibian JH. Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors. J Crohns Colitis 2013;
(6):467-73.
Biedermann L, Fournier N, Misselwitz B, Frei P, Zeitz J, Manser CN, et al. High rates of smoking
especially in female Crohn’s disease patients and low use of supportive measures to achieve smoking
cessation data from the Swiss IBD cohort study. J Crohns Colitis 2015; 9(10):819-29.
Kim ES, Cho KB, Park KS, Jang BI, Kim KO, Jeon SW, et al. Predictive factors of impaired quality of
life in Korean patients with inactive inflammatory bowel disease: association with functional gastrointestinal disorders and mood disorders. J Clin Gastroenterol 2013; 47(4):38-44.
Gracie DJ, Williams CJ, Sood R, Mumtaz S, Bholah MH, Hamlin PJ, et al. Negative effects on psychological health and quality of life of genuine irritable bowel syndrome-type symptoms in patients with
inflammatory bowel disease. Clin Gastroenterol Hepatol 2017; 15(3):376-384.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2012 Alejandro S Mayorga Garcés, Vilma E Rodríguez Vélez, Santiago E Dávila Bedoya, David Andrade Zamora, Javier H Carrillo Ubidia
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
